Trial NCT01673386

View at ClinicalTrials.gov 
Org. Study IDs: AV-951-12-205

Last trial update was posted on 2020-10-27

MeSH Interventions

Sunitinib Tivozanib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Metastatic Renal Cell Carcinoma

Stopping Reasons

Sponsor

Limitations And Caveats

The Sponsor terminated Study AV-951-12-205 before enrollment was completed, following the negative decision of the US FDA.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID